Joel Q Xue1. 1. GE Healthcare, Milwaukee, Wisconsin, USA. joel.xue@med.ge.com
Abstract
BACKGROUND: This article presents an effort of measuring QT interval with automatic computerized algorithms. The aims of the algorithms are consistency as well as accuracy. Multilead and multibeat information from a given segment of ECG are used for more consistent QT interval measurement. METHODS: A representative beat is generated from selected segment of each lead, and then a composite beat is formed by the representative beats of all independent leads. The end result of the QT measure is so-called global QT measurement, which usually correlates with the longest QT interval in multiple leads. Individual lead QT interval was estimated by using the global measurement as a starting point, and then adapted to the signal of the particular lead and beat. In general, beat-by-beat QT measurement is more prone to noise, therefore less reliable than the global estimation. It is usually difficult to know if difference of beat-by-beat QT interval is due to true physiological change or noise fluctuation. RESULTS: The algorithm was tested independently by a clinical database. It is also tested against action potential duration (APD) generated by a Cell-to-ECG forward-modeling based simulation signals. The modeling approach provided an objective test for the QT estimation. The modeling approach allowed us to evaluate the QT measurement versus APD. The mean error between the algorithm and cardiologist QT intervals is 3.95 +/- 5.5 ms, based on the large clinical trial database consisting of 15,910 ECGs. The mean error between QT intervals and maximum APD is 17 +/- 2.4, and the correlation coefficient is 0.99. CONCLUSIONS: The global QT interval measurement method presented in this study shows very satisfactory results against the CSE database and a large clinical trial database. The modeling test approach used in this study provides an alternative "gold standard" for QT interval measurement.
BACKGROUND: This article presents an effort of measuring QT interval with automatic computerized algorithms. The aims of the algorithms are consistency as well as accuracy. Multilead and multibeat information from a given segment of ECG are used for more consistent QT interval measurement. METHODS: A representative beat is generated from selected segment of each lead, and then a composite beat is formed by the representative beats of all independent leads. The end result of the QT measure is so-called global QT measurement, which usually correlates with the longest QT interval in multiple leads. Individual lead QT interval was estimated by using the global measurement as a starting point, and then adapted to the signal of the particular lead and beat. In general, beat-by-beat QT measurement is more prone to noise, therefore less reliable than the global estimation. It is usually difficult to know if difference of beat-by-beat QT interval is due to true physiological change or noise fluctuation. RESULTS: The algorithm was tested independently by a clinical database. It is also tested against action potential duration (APD) generated by a Cell-to-ECG forward-modeling based simulation signals. The modeling approach provided an objective test for the QT estimation. The modeling approach allowed us to evaluate the QT measurement versus APD. The mean error between the algorithm and cardiologist QT intervals is 3.95 +/- 5.5 ms, based on the large clinical trial database consisting of 15,910 ECGs. The mean error between QT intervals and maximum APD is 17 +/- 2.4, and the correlation coefficient is 0.99. CONCLUSIONS: The global QT interval measurement method presented in this study shows very satisfactory results against the CSE database and a large clinical trial database. The modeling test approach used in this study provides an alternative "gold standard" for QT interval measurement.
Authors: M S Fuller; G Sándor; B Punske; B Taccardi; R S MacLeod; P R Ershler; L S Green; R L Lux Journal: Circulation Date: 2000-08-08 Impact factor: 29.690
Authors: Claus Graff; Johannes J Struijk; Jørgen K Kanters; Mads P Andersen; Egon Toft; Benoît Tyl Journal: Clin Drug Investig Date: 2012-05-01 Impact factor: 2.859
Authors: Jörg Täubel; Georg Ferber; Leen Van Langenhoven; Teresa Del Bianco; Sara Fernandes; Dilshat Djumanov; Jørgen K Kanters; Claus Graff; A John Camm Journal: J Clin Pharmacol Date: 2019-01-11 Impact factor: 3.126
Authors: Jӧrg Täubel; Krishna Prasad; Giuseppe Rosano; Georg Ferber; Helen Wibberley; Samuel Thomas Cole; Leen Van Langenhoven; Sara Fernandes; Dilshat Djumanov; Atsushi Sugiyama Journal: J Clin Pharmacol Date: 2019-10-21 Impact factor: 3.126
Authors: Irena Andršová; Katerina Hnatkova; Martina Šišáková; Ondřej Toman; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Front Physiol Date: 2020-12-15 Impact factor: 4.566
Authors: Irena Andršová; Katerina Hnatkova; Martina Šišáková; Ondřej Toman; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Diagnostics (Basel) Date: 2020-12-16
Authors: Ondřej Toman; Katerina Hnatkova; Martina Šišáková; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Irena Andršová; Georg Schmidt; Marek Malik Journal: Front Physiol Date: 2022-04-01 Impact factor: 4.755
Authors: Irena Andršová; Katerina Hnatkova; Martina Šišáková; Ondřej Toman; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Sci Rep Date: 2021-07-12 Impact factor: 4.996
Authors: Philip M Gemmell; Karli Gillette; Gabriel Balaban; Ronak Rajani; Edward J Vigmond; Gernot Plank; Martin J Bishop Journal: Comput Biol Med Date: 2020-07-04 Impact factor: 4.589